Respiratory Inhalers Market- Size, Growth, Opportunity and Forecast to 2022-2031

Japan, Japan, Fri, 25 Mar 2022 07:49:31 / Comserve Inc. / – Respiratory Inhalers Market – Research Insights with Upcoming Trends, Opportunities, Competitive Analysis, Forecast to 2022-2031

In-depth analysis and data-driven insights on the impact of COVID-19 included in this Global Respiratory Inhalers Market report

the respiratory inhalers market by revenue is expected to grow at a CAGR of over 9% over the period 2022-2031.

The global respiratory inhaler market is one of the steadily growing segments of the medical device market. The steady growth can be attributed to the increasing prevalence of asthma, COPD and cystic fibrosis and the outbreak of the COVID-19 pandemic. The prevalence of COPD and other respiratory disorders requiring inhalers has increased at a significant rate in recent years across the world. COPD is expected to become the third leading cause of death globally by 2025, according to WHO. respiratory care such as inhalers. Moreover, the presence of established infrastructures in several countries in North America, Europe and APAC, coupled with the availability of well-developed technologies allowing early implementation of advanced inhalation technologies, increases the demand. of inhalers. Favorable government initiatives in emerging economies to improvise standard healthcare infrastructure and focus more on healthcare spending are also helping to focus on providing high-quality healthcare services.

Access the free PDF with charts and graphs: https://www.sdki.jp/sample-request-91189

The following factors are likely to contribute to the growth of the respiratory inhalers market over the forecast period:
• Increased use of smart inhaler
• Introduction of soft mist inhalers
• Increase in the target population
• Increased use of inhalers due to COVID-19

The study examines the current respiratory inhaler market scenario and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth catalysts, restraints, and trends. The report offers both the demand and supply side of the market. It profiles and reviews the leading companies and other eminent ones operating in the market.

Request a sample for more information: https://www.sdki.jp/sample-request-91189

Segmentation of the global respiratory inhalers market

The global respiratory inhalers market research report includes detailed segmentation by products, patients, distribution channels and geographies. The metered-dose inhaler segment is expected to reach over 2.5 billion by 2025 due to the COVID-19 outbreak, which has led to increased usage of inhalers among patients with respiratory diseases. Pressurized metered dose inhalers (pMDIs) and dry powder inhalers (DPIs) are commonly used by end users. pMDIs are mainly used in developing and underdeveloped countries due to their low price and easy availability in pharmacies. DPI, breath-actuated inhalers, and soft-mist inhalers are widely used in developed countries such as the United States, United Kingdom, and Germany, as treatment in these countries is covered by health insurance policies. insurance and reimbursement. Developed countries are the mature market, where the most advanced versions of smart inhalers are used by people. MDIs are considered the first line of treatment for major respiratory disorders such as COPD and asthma. However, a major challenge facing the segment is the lack of awareness among patients and healthcare providers regarding the correct usage of metered dose inhalers.

The respiratory inhaler market is segmented into pediatric and adult age groups. In. In 2019, the adult segment accounted for 68% and the pediatric population accounted for a 32% share in the respiratory inhaler market. The adult population is widely exposed to several environmental risk factors such as air and workplace pollution and tobacco consumption. This contributes to the high share of the adult population in the market. While the prevalence of asthma is increasing in several countries, multiple factors affect the incidence of asthma in the adult population. With the eruption of the COVID-19 pandemic, the number of infected adults exceeds that of the pediatric and neonatal populations. Therefore, the demand for inhalers has increased significantly around the world due to the spread of the virus.
The hospital pharmacy segment accounted for a 47% share. Hospitals are the first point of contact for the assessment and treatment of respiratory diseases such as asthma and COPD. As the number of hospitals increased over the period, the number of hospital pharmacies also increased. In middle- and low-income countries, several small clinics and nursing homes have links with hospital pharmacies to refer patients to purchase branded medical devices for use.

Segmentation by products
• Metered dose inhaler
• Dry powder inhaler
Segmentation by patient
• Adults
• Pediatric
Segmentation by distribution channel
• Hospital pharmacies
• Retail
• In line

OVERVIEW BY GEOGRAPHY
North America has dominated the global inhaler market, and this dominance is mainly due to the increase in the prevalence of several respiratory diseases. The United States was the first to adopt the latest inhaler technology to reduce the rate of COPD. In North America, the United States and Canada have seen widespread adoption of these devices over the past decade. Rising levels of pollution, along with the increasing number of cases of respiratory ailments, is one of the main reasons driving the overall demand in the region. Also, since the outbreak of the COVID pandemic, the need for inhalers has increased dramatically in ICUs and emergency rooms. A large population on ventilators is assisted with inhalers for increased drug efficacy. Although the market is expected to grow at a slower rate than other regions, there is an increase in the demand for inhalers in the region, especially in the United States owing to the COVID-19 pandemic. The country will experience growth as national health spending is expected to increase at an average annual rate of more than 5% over the period 2019-2028, reaching $6.2 trillion by 2028.

Segmentation by geography
• North America
o United States
o Canada
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• APAC
o China
o Japan
o South Korea
o Australia
o India
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa
o South Africa
o Saudi Arabia
o Turkey

OVERVIEW OF SUPPLIERS
The global respiratory inhalers market share is fragmented with the presence of several global, regional and local vendors offering a wide range of products. GSK, Novartis, BOEHRINGER INGELHEIM, Cipla and AstraZeneca are the major players dominating the global inhaler market. Although large vendors dominate the market, they face strong competition from regional and local companies in India, China, Italy and Germany. Many regional vendors also offer cost-effective products in Europe, APAC, Middle East and Africa regions.

Important Suppliers
• GlaxoSmithKline
• Novartis
• Boehringer Ingelheim
• Cipla
• Astra Zeneca

Other Important Suppliers
• Propeller Health
• Beximco Pharmaceuticals (Beximco Pharma)
• H&T press room
• Cohero Health
• CHIESI Pharmaceuticals
• Mundipharma
• 3M
• HELTMAN Medical
• Adherium
• Lucky’s Pharma
• Amiko Digital Health
• Teva Pharmaceutical Industries
• Findair Sp.zoo
• Vectorura Group

ANSWERS TO KEY QUESTIONS
1. What is the respiratory inhaler market size and growth rate during the forecast period?
2. What are the factors impacting the growth of respiratory inhalers market share?
3. How is the growth of the hospital pharmacy segment influencing the growth of the respiratory inhalers market?
4. Who are the major vendors in the respiratory inhaler market and what are their market shares?
5. What is the impact of the COVID-19 pandemic on the respiratory inhalers market share?

The dynamic nature of the business environment in today’s global economy increases the need among business professionals to update themselves with current market situations. To meet these needs, Shibuya Data Count provides market research reports to various professionals in different verticals, such as healthcare and pharmaceuticals, IT and telecommunications, chemicals and advanced materials, goods consumption and food, energy and electricity, manufacturing and construction, industry. automation and equipment and agriculture and related activities, among others.

For more information please contact:

Hina Miyazu

Shibuya Data Count
Email: [email protected]
Tel: + 81 3 45720790

The post office Respiratory Inhalers Market- Size, Growth, Opportunity and Forecast to 2022-2031 appeared first on Comserveonline.